Literature DB >> 10704630

The relationship of oxidized lipids to coronary artery stenosis.

F A Kummerow1, R M Olinescu, L Fleischer, B Handler, S V Shinkareva.   

Abstract

A total of 1200 patients with angina were cardiac catheterized establishing that 63% had 70-100% stenosis, 12% had 10-69% stenosis of one or more of their coronary arteries and 25% had microvascular angina listed as 0% stenosis. Prior to catheterization 10 ml of blood was drawn and the plasma subjected to analysis for the concentration of cholesterol, lipid peroxides (LPX), total antioxidant capacity (TAOC), fibrinogen (FB), ceruloplasmin (CP) and activation of polymorphonuclear leukocytes (PMNLs). Comparisons were made to non-smoking controls without angina. Significant differences in LPX were found between the patients with 0 and 10-69% stenosis (P<0.001), with 10-69 and 70-100% stenosis (P<0.001), and with 0 and 70-100% stenosis (P<0.001). Under 70 years of age there was a significant difference in LPX between patients with all levels of stenosis and age and sex matched controls (P<0.001). Differences in the mean plasma cholesterol concentration for different levels in the degree of stenosis were not significant, indicating that LPX provided consistent data on the severity of stenosis while the plasma cholesterol concentration did not. Compared with controls an increase in activation of PMNLs (P<0.01), an increase in concentration of both FB and CP (P<0.01) and a decrease in total antioxidant capacity were noted in the plasma of catheterized patients. In summary the concentration of oxidation products rather than the concentration of cholesterol in the plasma identified stenosis in cardiac catheterized patients.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10704630     DOI: 10.1016/s0021-9150(99)00378-0

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  7 in total

1.  Antioxidants and cardiovascular disease: Still a topic of interest.

Authors:  Shuko Nojiri; Hiroyuki Daida; Yutaka Inaba
Journal:  Environ Health Prev Med       Date:  2004-09       Impact factor: 3.674

2.  Interaction between sphingomyelin and oxysterols contributes to atherosclerosis and sudden death.

Authors:  Fred A Kummerow
Journal:  Am J Cardiovasc Dis       Date:  2013-02-17

3.  Uric Acid and Coronary Artery Disease, Two Sides of a Single Coin: A Determinant of Antioxidant System or a Factor in Metabolic Syndrome.

Authors:  Babak Bagheri; Mehryar Zargari; Fatemeh Meshkini; Kolsoum Dinarvand; Vahid Mokhberi; Soheil Azizi; Mehdi Rasouli
Journal:  J Clin Diagn Res       Date:  2016-02-01

4.  Reactive oxygen metabolites are closely associated with the diagnosis and prognosis of coronary artery disease.

Authors:  Yoshihiro Hirata; Eiichiro Yamamoto; Takanori Tokitsu; Hiroaki Kusaka; Koichiro Fujisue; Hirofumi Kurokawa; Koichi Sugamura; Hirofumi Maeda; Kenichi Tsujita; Koichi Kaikita; Seiji Hokimoto; Seigo Sugiyama; Hisao Ogawa
Journal:  J Am Heart Assoc       Date:  2015-01-28       Impact factor: 5.501

5.  The Pivotal Role of a Novel Biomarker of Reactive Oxygen Species in Chronic Kidney Disease.

Authors:  Yoshihiro Hirata; Eiichiro Yamamoto; Takanori Tokitsu; Koichiro Fujisue; Hirofumi Kurokawa; Koichi Sugamura; Kenji Sakamoto; Kenichi Tsujita; Tomoko Tanaka; Koichi Kaikita; Seiji Hokimoto; Seigo Sugiyama; Hisao Ogawa
Journal:  Medicine (Baltimore)       Date:  2015-06       Impact factor: 1.889

6.  Prenatal exposure to cigarette smoke induces diet- and sex-dependent dyslipidemia and weight gain in adult murine offspring.

Authors:  Sheung P Ng; Daniel J Conklin; Aruni Bhatnagar; Duane D Bolanowski; Jessica Lyon; Judith T Zelikoff
Journal:  Environ Health Perspect       Date:  2009-04-13       Impact factor: 9.031

7.  High Cholesterol Diet-Induced Changes in Oxysterol and Scavenger Receptor Levels in Heart Tissue.

Authors:  Erdi Sozen; Burak Yazgan; Ali Sahin; Umit Ince; Nesrin Kartal Ozer
Journal:  Oxid Med Cell Longev       Date:  2018-06-13       Impact factor: 6.543

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.